| Sample No | Sample Sourcea | Sample | Arsenic/mgL−1 | |||
| AHG-AAS (n = 5) | Proposed Method (n = 5) | |||||
| Found | RSD (%)b | Found | RSD (%)b | |||
| 1 | Arsenicosis patient (skin cancer) (Male) | Blood | 2.21 | 1.0 | 2.25 | 1.0 |
| Urine | 0.58 | 0.8 | 0.62 | 0.5 | ||
| 2 | Arsenicosis patient (skin cancer) (Male) | Blood | 1.58 | 1.0 | 1.62 | 1.2 |
| Urine | 0.35 | 0.5 | 0.41 | 0.8 | ||
| 3 | Arsenicosis patient (skin cancer) (Male) | Blood | 5.15 | 1.7 | 5.25 | 1.8 |
| Urine | 1.36 | 1.1 | 1.42 | 1.0 | ||
| 4 | Asthma (Male) | Blood | 0.85 | 1.0 | 0.92 | 1.0 |
| Urine | 0.23 | 0.05 | 0.24 | 0.06 | ||
| 5 | Liver cirrhosis (Female) | Blood | 1.25 | 1.0 | 1.28 | 1.1 |
| Urine | 0.31 | 0.5 | 0.32 | 0.6 | ||
| 6 | Skin disease | Blood | 0.95 | 0.8 | 1.00 | 0.9 |
| Urine | 0.23 | 0.5 | 0.25 | 0.8 | ||